| Literature DB >> 24527415 |
Min-Gyu Kang1, Woo-Jung Song2, Han-Ki Park2, Kyung-Hwan Lim1, Su-Jung Kim2, Suh-Young Lee2, Sae-Hoon Kim1, Sang-Heon Cho2, Kyung-Up Min2, Yoon-Seok Chang1.
Abstract
The role of food additives in chronic urticaria (CU) is still under investigation. In this study, we aimed to explore the association between food additives and CU by using the basophil activation test (BAT). The BAT using 15 common food additives was performed for 15 patients with CU who had a history of recurrent urticarial aggravation following intake of various foods without a definite food-specific IgE. Of the 15 patients studied, two (13.3%) showed positive BAT results for one of the tested food additives. One patient responded to monosodium glutamate, showing 18.7% of CD203c-positive basophils. Another patient showed a positive BAT result to sodium benzoate. Both patients had clinical correlations with the agents, which were partly determined by elimination diets. The present study suggested that at least a small proportion of patients with CU had symptoms associated with food additives. The results may suggest the potential utility of the BAT to identity the role of food additives in CU.Entities:
Keywords: Basophil activation test; Food additives; Hypersensitivity; Monosodium glutamate; Sodium benzoate; Urticaria
Year: 2014 PMID: 24527415 PMCID: PMC3921299 DOI: 10.7762/cnr.2014.3.1.9
Source DB: PubMed Journal: Clin Nutr Res ISSN: 2287-3732
Baseline characteristics of 15 chronic urticaria patients
Values are presented as means ± standard deviation.
*The skin prick test was performed with a standardized technique using 55 kinds of commercially available extracts of a food allergen panel (Allergopharma, Reinbeck, Germany) as well as histamine and saline as a positive and negative control, respectively. The skin prick test results were considered positive when the wheal size for allergen was ≥3 mm and the wheal size for an allergen was greater than the wheal size for histamine; †Food-specific IgE was measured by using the RIDA Allergy Screen (R-biopharm, Darmastadt, Germany) or UniCAP (Thermo Fischer, Uppsala, Sweden) and was considered positive when the allergen-specific IgE level was ≥0.35 kU/L (≥class 1).
Summary of the basophil activation tests and other profiles of the study participants
F: female, M: male, tIgE: total IgE (IU/mL), SPT: skin prick test, MAST: multiple allergen stimulation test, which was measured by using RIDA allergen screening, PB: patient's background, PC: patient's control, FC I: food colorant mix I, FC II: food colorant mix II.
The BAT results presented as the percentage of activated basophils; Peripheral eosinophil counts are presented as cells/µL.
*Considered positive when the wheal size for the allergen was ≥3 mm and the wheal size for the allergen was greater than that for histamine; †Considered positive when the allergen-specific IgE level was ≥0.35 kU/L (≥class 1); ‡Considered positive when the allergen-specific IgE level was >3.5 kU/L (≥3+ or class 3).
Figure 1Basophil activation test results for patient 1 showing monosodium glutamate (MSG) hypersensitivity. (A) The basophils were identified as SSClow/CCR3high from the gated lymphocytes. (B) As a negative control, background basophil activation with stimulation buffer only (1.3%). (C) As a positive control, basophil activation with anti-specific IgE antibody (71.4%). (D) The percentage of activated basophils stimulated with MSG was 18.7%. The stimulation index (SI) with MSG was 15.0.
Figure 2Basophil activation test results for patient 2 showing sodium benzoate hypersensitivity. (A) The basophils were identified as SSClow/CCR3high from the gated lymphocytes. (B) As a negative control, background basophil activation with stimulation buffer only (3.1%). (C) As a positive control, basophil activation with anti-specific IgE antibody (8.3%). (D) The percentage of activated basophils treated with sodium benzoate was 37.5%. The stimulation index (SI) with sodium benzoate was 12.1.